Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hyatt Regency Bethesda

Feb 10, 2014 8:15 AM - Feb 11, 2014 5:15 PM

One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326

Benefit-Risk Assessment from Inception to Maturation: Aligning Regulatory and Industry Goals

Session 3 - Widening the Perspective: Reflections from Vital Partners Beyond Industry and Regulators

Session Chair(s)

Robyn R. Lim, PhD

Robyn R. Lim, PhD

Senior Science Advisor, Health Products and Food Branch

Health Canada, Canada

What do patients consider to be a medicine's most important positive and negative effects and uncertainties? Why do payors decide to reimburse a medicine? This session will reveal some perspectives beyond those of regulators and industry that are vital to achieving a future state in which the health community coordinates itself to best effect. We will explore opportunities for benefit-risk approaches to incorporate and inform patients' views, improve medicines development, enhance medicines management and optimize health outcomes.

Speaker(s)

Edmund Joseph Pezalla, MD, MPH

Payor Perspective

Edmund Joseph Pezalla, MD, MPH

Enlightment Bioconsult, LLC, United States

Chief Executive Officer

Louise  Binder, JD

Patient Perspective

Louise Binder, JD

Save Your Skin Foundation, Canada

Health Policy Consultant

Linda  Wilhelm

Linda Wilhelm

Canadian Arthritis Network , Canada

Consumer Advisory Council

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.